1. Japan Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
HABA Laboratories, Inc.

HABA Laboratories, Inc.

TTSE:4925
1,674.00
JPY
+1.00
(+0.06%)
6.43BMarket Cap
Nov 13Next Earn
HABA Laboratories, Inc.
TSE:4925
(Tokyo Stock Exchange)

Recent

price

1,674.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
3,002.13
3,451.74
3,364.14
3,504.77
3,348.66
3,765.16
4,101.91
4,546.86
4,894.65
4,746.13
3,783.53
3,413.65
3,183.39
3,259.06
3,189.69
3,210.73
- -
Revenue per Share
5.62
136.73
2.56
232.95
11.39
249.74
308.52
406.2
530.93
339.36
57.23
-71.14
-187.19
-560.26
152.47
201.07
- -
Basic EPS, GAAP
-26.67
30.18
310.8
162.03
-103.45
289.56
118.11
452.65
368.36
-60.58
-91.75
403.79
-61.53
-270.05
372.63
298.23
- -
Free Cash Flow per Basic Share
19.95
20.02
19.98
20.02
20.02
19.99
20
29.96
30.01
40.63
40.02
39.96
40.01
39.98
40
40.05
- -
Dividend per Share
1,338.02
1,454.95
1,438.44
1,652.01
1,643.97
1,873.22
2,161.8
2,538.11
3,038.38
3,166.11
3,183.64
3,077.51
2,849.03
2,249.65
2,360.75
2,521.82
- -
Book Value per Share
1,189.48
1,180.75
1,192.25
1,479.69
1,532.7
1,788.74
1,989.39
2,341.32
2,861.24
2,965.64
3,045.52
2,985.97
2,765.52
2,249.65
2,336.03
2,492.03
- -
Tangible Book Value per Share
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Basic Weighted Avg Shares
11,810
13,579
13,234
13,787
13,181
14,811
16,136
17,886
19,254
18,370
14,308
12,909
12,038
12,324
12,062
12,141
- -
Sales/Revenue/Turnover
5.59
7.63
3.23
9.1
2.15
10.3
10.97
13.42
16.08
10.88
1.59
-2.45
-5.06
-1.52
4.89
5.99
- -
Operating Margin (%)
457
631
622
634
584
616
538
617
617
630
669
708
560
519
159
186
- -
Depreciation Expense
22
538
10
916
45
982
1,214
1,598
2,088
1,313
216
-269
-708
-2,119
577
760
- -
Net Income, GAAP
92.39
40.97
94.1
44.2
81.28
41.06
30.45
32.88
32.05
31.86
23.78
- -
- -
- -
9.31
10.55
- -
Effective Tax Rate (%)
0.19
3.96
0.08
6.65
0.34
6.63
7.52
8.93
10.85
7.15
1.51
-2.08
-5.88
-17.19
4.78
6.26
- -
Profit Margin (%)
1,696
1,836
1,840
2,215
3,176
4,049
4,555
5,248
7,243
7,750
7,861
7,540
6,545
6,263
6,377
7,434
- -
Working Capital
2,415
2,653
2,358
2,223
1,921
1,451
1,343
1,094
829
1,680
1,914
1,473
1,032
1,000
728
608
- -
LT Debt
5,287
5,725
5,658
6,499
6,467
7,369
8,504
9,984
11,952
11,973
12,039
11,638
10,774
8,507
8,927
9,536
- -
Total Equity
0.45
5.18
0.22
6.02
0.45
8.01
10.75
12.98
15.07
9.12
1.11
- -
- -
- -
4.87
5.94
- -
Return on Invested Capital (%)
0.15
5.11
0.12
8.52
0.49
9.22
11.19
13.5
15.78
9.11
1.44
- -
- -
- -
5.48
7.22
- -
Return on Capital (%)
0.42
9.79
0.18
15.08
0.69
14.2
15.29
17.29
19.04
10.98
1.8
-2.27
-6.32
-21.98
6.61
8.24
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
732
580
- -
LT Borrowings
668
608
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
6,398
6,432
6,455

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
8,794
9,780
- -
Cash, Cash Equivalents & STI
4,383
5,785
- -
Accounts Receivable, Net
1,090
1,265
- -
Inventories
3,123
2,571
- -
Total Current Liabilities
2,344
2,346
- -
Payables & Accruals
- -
- -
- -
ST Debt
732
580
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.32%
-4.01%
6.82%
Free Cash Flow
-43.73%
-114.89%
-19.97%
Net Income, GAAP
0.81%
8.56%
31.88%
Sales/Revenue/Turnover
-1.49%
-3.12%
0.66%
Total Cash Common Dividend
7.96%
0.02%
0.12%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
12,062
2026
- -
- -
- -
- -
12,141
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
152.47
2026
- -
- -
- -
- -
201.07
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
40
2026
- -
- -
- -
- -
40.05
2027
- -
- -
- -
- -
- -
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
HABA Laboratories, Inc. (4925.T) manufactures and sells skin care products, hair and body care products, cosmetics, quasi-drugs, and nutritional supplements in Japan and internationally; its core offerings include cleansers, Squalane beauty oil, additive-free makeup series, skincare essentials such as lotions and essences, and dietary supplements distributed through department stores, online shopping, mail order catalogs like BIYOU TECHOU, over seventy HABA shops, drug and variety stores, and delivery centers. Founded in May 1983 and headquartered at 1-24-11 Kanda Sudacho, Chiyoda-ku, Tokyo 101-0041, Japan, the company operates consolidated subsidiaries including HABA Inc. and HABA Cosmetics Inc., employs approximately 568 to 673 people, and generates annual sales around 12 to 13 billion JPY primarily from its cosmetics business in Japan with international expansion. It lists on the Tokyo Stock Exchange JASDAQ since June 2003 and maintains a focus on additive-free, natural products emphasizing skin's healing power without parabens, artificial fragrances, or mineral oil. Recent financial results show fiscal year ending March 2025 revenue of 12.06 billion JPY, down 2.13% year-over-year, with quarterly revenue declines including -1.57% in June 2025 and ongoing operations through wholesale to retailers like Mitsukoshi and Loft alongside direct customer channels.